Killer cell lectin-like receptor G1 inhibits NK cell function through activation of adenosine 59-monophosphate-Activated protein kinase

Journal of Immunology

Volumn 197, Issue 7, 2016, Pages 2891-2899

  Muller Durovic, Bojana ^a   Lanna, Alessio ^a,b   Covre, Luciana Polaco ^a,c   Mills, Rachel S ^a   Henson, Sian M ^d   Akbar, Arne N ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c FEDERAL UNIVERSITY OF ESPÍRITO SANTO   (Brazil)

^d QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD16 ANTIGEN; CD56 ANTIGEN; GAMMA INTERFERON; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; LYMPHOCYTE MEMBRANE RECEPTOR; NATURAL KILLER CELL LECTIN LIKE RECEPTOR G1; PROTEIN TYROSINE PHOSPHATASE SHP 2; UNCLASSIFIED DRUG; NATURAL KILLER CELL LECTIN LIKE RECEPTOR;

ADULT; AGED; AGING; ARTICLE; CELL FUNCTION; CELL MEDIATED CYTOTOXICITY; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; NATURAL KILLER CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; VERY ELDERLY; CELL CULTURE; ENZYMOLOGY; FEMALE; IMMUNOLOGY; MALE; METABOLISM; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; AMP-ACTIVATED PROTEIN KINASES; CELLS, CULTURED; FEMALE; HUMANS; KILLER CELLS, NATURAL; MALE; RECEPTORS, NK CELL LECTIN-LIKE; YOUNG ADULT;

EID: 84989820541     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1600590     Document Type: Article

References (49)

1. Akbar, A. N., P. C. Beverley, and M. Salmon. 2004. Will telomere erosion lead to a loss of T-cell memory? Nat. Rev. Immunol. 4: 737-743.
2. Sprenger, M. J., P. G. Mulder, W. E. Beyer, R. Van Strik, and N. Masurel. 1993. Impact of influenza on mortality in relation to age and underlying disease, 1967- 1989. Int. J. Epidemiol. 22: 334-340.
3. Ackermann, R. J., and P. W. Monroe. 1996. Bacteremic urinary tract infection in older people. J. Am. Geriatr. Soc. 44: 927-933.
4. Berger, N. A., P. Savvides, S. M. Koroukian, E. F. Kahana, G. T. Deimling, J. H. Rose, K. F. Bowman, and R. H. Miller. 2006. Cancer in the elderly. Trans. Am. Clin. Climatol. Assoc. 117: 147-155; discussion 155-156.
5. Kaech, S. M., and R. Ahmed. 2001. Memory CD8+ T cell differentiation: initial antigen encounter triggers a developmental program in naive cells. Nat. Immunol. 2: 415-422.
6. French, A. R., and W. M. Yokoyama. 2003. Natural killer cells and viral infections. Curr. Opin. Immunol. 15: 45-51.
7. Chaix, J., M. S. Tessmer, K. Hoebe, N. Fuséri, B. Ryffel, M. Dalod, L. Alexopoulou, B. Beutler, L. Brossay, E. Vivier, and T. Walzer. 2008. Cutting edge: priming of NK cells by IL-18. J. Immunol. 181: 1627-1631.
8. Parham, P., and A. Moffett. 2013. Variable NK cell receptors and their MHC class I ligands in immunity, reproduction and human evolution. Nat. Rev. Immunol. 13: 133-144.
9. Orange, J. S. 2013. Natural killer cell deficiency. J. Allergy Clin. Immunol. 132: 515-525, quiz 526.
10. Lutz, C. T., M. B. Moore, S. Bradley, B. J. Shelton, and S. K. Lutgendorf. 2005. Reciprocal age related change in natural killer cell receptors for MHC class I. Mech. Ageing Dev. 126: 722-731.
11. Di Lorenzo, G., C. R. Balistreri, G. Candore, D. Cigna, A. Colombo, G. C. Romano, A. T. Colucci, F. Gervasi, F. Listì, M. Potestio, and C. Caruso. 1999. Granulocyte and natural killer activity in the elderly. Mech. Ageing Dev. 108: 25-38.
12. Le Garff-Tavernier, M., V. Béziat, J. Decocq, V. Siguret, F. Gandjbakhch, E. Pautas, P. Debré, H. Merle-Beral, and V. Vieillard. 2010. Human NK cells display major phenotypic and functional changes over the life span. Aging Cell 9: 527-535.
13. Lutz, C. T., A. Karapetyan, A. Al-Attar, B. J. Shelton, K. J. Holt, J. H. Tucker, and S. R. Presnell. 2011. Human NK cells proliferate and die in vivo more rapidly than T cells in healthy young and elderly adults. J. Immunol. 186: 4590-4598.
14. Hazeldine, J., and J. M. Lord. 2013. The impact of ageing on natural killer cell function and potential consequences for health in older adults. Ageing Res. Rev. 12: 1069-1078.
15. Lanier, L. L. 2008. Up on the tightrope: natural killer cell activation and inhibition. Nat. Immunol. 9: 495-502.
16. Parham, P. 2004. Killer cell immunoglobulin-like receptor diversity: balancing signals in the natural killer cell response. Immunol. Lett. 92: 11-13.
17. Guthmann, M. D., M. Tal, and I. Pecht. 1995. A secretion inhibitory signal transduction molecule on mast cells is another C-Type lectin. Proc. Natl. Acad. Sci. USA 92: 9397-9401.
18. Ito, M., T. Maruyama, N. Saito, S. Koganei, K. Yamamoto, and N. Matsumoto. 2006. Killer cell lectin-like receptor G1 binds three members of the classical cadherin family to inhibit NK cell cytotoxicity. J. Exp. Med. 203: 289-295.
19. Voehringer, D., M. Koschella, and H. Pircher. 2002. Lack of proliferative capacity of human effector and memory T cells expressing killer cell lectinlike receptor G1 (KLRG1). Blood 100: 3698-3702.
20. Lopez-Vergès, S., J. M. Milush, S. Pandey, V. A. York, J. Arakawa-Hoyt, H. Pircher, P. J. Norris, D. F. Nixon, and L. L. Lanier. 2010. CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16+ NK-cell subset. Blood 116: 3865-3874.
21. Ouyang, Q., W. M. Wagner, D. Voehringer, A. Wikby, T. Klatt, S. Walter, C. A. Muller, H. Pircher, and G. Pawelec. 2003. Age-Associated accumulation of CMV-specific CD8+ T cells expressing the inhibitory killer cell lectin-like receptor G1 (KLRG1). Exp. Gerontol. 38: 911-920.
22. Henson, S. M., O. Franzese, R. Macaulay, V. Libri, R. I. Azevedo, S. Kiani- Alikhan, F. J. Plunkett, J. E. Masters, S. Jackson, S. J. Griffiths, et al. 2009. KLRG1 signaling induces defective Akt (ser473) phosphorylation and proliferative dysfunction of highly differentiated CD8+ T cells. Blood 113: 6619-6628.
23. Henson, S. M., and A. N. Akbar. 2009. KLRG1-more than a marker for T cell senescence. Age (Dordr.) 31: 285-291.
24. Goronzy, J. J., G. Li, M. Yu, and C. M. Weyand. 2012. Signaling pathways in aged T cells -A reflection of T cell differentiation, cell senescence and host environment. Semin. Immunol. 24: 365-372.
25. Chou, J. P., and R. B. Effros. 2013. T cell replicative senescence in human aging. Curr. Pharm. Des. 19: 1680-1698.
26. Bigley, A. B., G. Spielmann, N. Agha, and R. J. Simpson. 2015. The effects of age and latent cytomegalovirus infection on NK-cell phenotype and exercise responsiveness in man. Oxid. Med. Cell. Longev. 2015: 979645.
27. Hayhoe, R. P., S. M. Henson, A. N. Akbar, and D. B. Palmer. 2010. Variation of human natural killer cell phenotypes with age: identification of a unique KLRG1-negative subset. Hum. Immunol. 71: 676-681.
28. Huntington, N. D., H. Tabarias, K. Fairfax, J. Brady, Y. Hayakawa, M. A. Degli- Esposti, M. J. Smyth, D. M. Tarlinton, and S. L. Nutt. 2007. NK cell maturation and peripheral homeostasis is associated with KLRG1 up-regulation. J. Immunol. 178: 4764-4770.
29. Wang, J. M., Y. Q. Cheng, L. Shi, R. S. Ying, X. Y. Wu, G. Y. Li, J. P. Moorman, and Z. Q. Yao. 2013. KLRG1 negatively regulates natural killer cell functions through the Akt pathway in individuals with chronic hepatitis C virus infection. J. Virol. 87: 11626-11636.
30. Robbins, S. H., K. B. Nguyen, N. Takahashi, T. Mikayama, C. A. Biron, and L. Brossay. 2002. Cutting edge: inhibitory functions of the killer cell lectin-like receptor G1 molecule during the activation of mouse NK cells. J. Immunol. 168: 2585-2589.
31. Evans, A. M., C. Peers, C. N. Wyatt, P. Kumar, and D. G. Hardie. 2012. Ion channel regulation by the LKB1-AMPK signalling pathway: The key to carotid body activation by hypoxia and metabolic homeostasis at the whole body level. Adv. Exp. Med. Biol. 758: 81-90.
32. Lanna, A., S. M. Henson, D. Escors, and A. N. Akbar. 2014. The kinase p38 activated by the metabolic regulator AMPK and scaffold TAB1 drives the senescence of human T cells. Nat. Immunol. 15: 965-972.
33. Milush, J. M., B. R. Long, J. E. Snyder-Cappione, A. J. Cappione, III, V. A. York, L. C. Ndhlovu, L. L. Lanier, J. Michaëlsson, and D. F. Nixon. 2009. Functionally distinct subsets of human NK cells and monocyte/DClike cells identified by coexpression of CD56, CD7, and CD4. Blood 114: 4823-4831.
34. Neri, S., E. Mariani, A. Meneghetti, L. Cattini, and A. Facchini. 2001. Calceinacetyoxymethyl cytotoxicity assay: standardization of a method allowing additional analyses on recovered effector cells and supernatants. Clin. Diagn. Lab. Immunol. 8: 1131-1135.
35. Borrego, F., M. C. Alonso, M. D. Galiani, J. Carracedo, R. Ramirez, B. Ostos, J. Peña, and R. Solana. 1999. NK phenotypic markers and IL2 response in NK cells from elderly people. Exp. Gerontol. 34: 253-265.
36. Chidrawar, S. M., N. Khan, Y. L. Chan, L. Nayak, and P. A. Moss. 2006. Ageing is associated with a decline in peripheral blood CD56bright NK cells. Immun. Ageing 3: 10.
37. Hofmann, M., O. Schweier, and H. Pircher. 2012. Different inhibitory capacities of human and mouse KLRG1 are linked to distinct disulfide-mediated oligomerizations. Eur. J. Immunol. 42: 2484-2490.
38. Campisi, J., and F. d'Adda di Fagagna. 2007. Cellular senescence: When bad things happen to good cells. Nat. Rev. Mol. Cell Biol. 8: 729-740.
39. Di Mitri, D., R. I. Azevedo, S. M. Henson, V. Libri, N. E. Riddell, R. Macaulay, D. Kipling, M. V. Soares, L. Battistini, and A. N. Akbar. 2011. Reversible senescence in human CD4+CD45RA+CD272 memory T cells. J. Immunol. 187: 2093-2100.
40. Rolf, J., M. Zarrouk, D. K. Finlay, M. Foretz, B. Viollet, and D. A. Cantrell. 2013. AMPKa1: A glucose sensor that controls CD8 T-cell memory. Eur. J. Immunol. 43: 889-896.
41. Sanders, M. J., P. O. Grondin, B. D. Hegarty, M. A. Snowden, and D. Carling. 2007. Investigating the mechanism for AMP activation of the AMP-Activated protein kinase cascade. Biochem. J. 403: 139-148.
42. Suter, M., U. Riek, R. Tuerk, U. Schlattner, T. Wallimann, and D. Neumann. 2006. Dissecting the role of 59-AMP for allosteric stimulation, activation, and deactivation of AMP-Activated protein kinase. J. Biol. Chem. 281: 32207-32216.
43. Göransson, O., A. McBride, S. A. Hawley, F. A. Ross, N. Shpiro, M. Foretz, B. Viollet, D. G. Hardie, and K. Sakamoto. 2007. Mechanism of action of A-769662, a valuable tool for activation of AMP-Activated protein kinase. J. Biol. Chem. 282: 32549-32560.
44. Soule, H. D., T. M. Maloney, S. R. Wolman, W. D. Peterson Jr., R. Brenz, C. M. McGrath, J. Russo, R. J. Pauley, R. F. Jones, and S. C. Brooks. 1990. Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res. 50: 6075-6086.
45. Mace, E. M., P. Dongre, H. T. Hsu, P. Sinha, A. M. James, S. S. Mann, L. R. Forbes, L. B. Watkin, and J. S. Orange. 2014. Cell biological steps and checkpoints in accessing NK cell cytotoxicity. Immunol. Cell Biol. 92: 245-255.
46. Cerwenka, A., and L. L. Lanier. 2016. Natural killer cell memory in infection, inflammation and cancer. Nat. Rev. Immunol. 16: 112-123.
47. Crawford, A., and E. J. Wherry. 2007. Inhibitory receptors: Whose side are they on? Nat. Immunol. 8: 1201-1203.
48. Pardoll, D. M. 2012. The blockade of immune checkpoints in cancer immunotherapy. Nat. Rev. Cancer 12: 252-264.
49. Blaser, C., M. Kaufmann, and H. Pircher. 1998. Virus-Activated CD8 T cells and lymphokine-Activated NK cells express the mast cell function-Associated antigen, an inhibitory C-Type lectin. J. Immunol. 161: 6451-6454.